Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.50 |
| ▸ | GLS2 | Q9UI32 | 3/20 | 0.49 |
| ▸ | FAAH | O00519 | 2/20 | 0.45 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28751563 | 1.00 | PRKCA (0.50) | PRKCAGLS2FAAHPRKCDGPR84 | |
| SCHEMBL30731537 | 1.00 | PRKCA (0.50) | PRKCAGLS2FAAHPRKCDGPR84 | |
| SCHEMBL29655357 | 1.00 | PRKCA (0.50) | PRKCAGLS2FAAHPRKCDGPR84 | |
| SCHEMBL31626952 | 1.00 | PRKCA (0.50) | PRKCAGLS2FAAHPRKCDGPR84 | |
| SCHEMBL2486538 | 1.00 | PRKCA (0.50) | PRKCAGLS2FAAHPRKCDGPR84 | |
| SCHEMBL276887 | 1.00 | PRKCA (0.50) | PRKCAGLS2FAAHPRKCDGPR84 | |
| SCHEMBL23930714 | 1.00 | PRKCA (0.50) | PRKCAGLS2FAAHPRKCDGPR84 | |
| SCHEMBL19971880 | 1.00 | PRKCA (0.50) | PRKCAGLS2FAAHPRKCDGPR84 | |
| SCHEMBL22471650 | 1.00 | PRKCA (0.50) | PRKCAGLS2FAAHPRKCDGPR84 | |
| SCHEMBL27642486 | 1.00 | PRKCA (0.50) | PRKCAGLS2FAAHPRKCDGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116068119-A | Detection method of kidney-tonifying essence-replenishing oral liquid | 九芝堂股份有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-111122735-B | Ligusticum wallichii medicine quality detection method | 贵州景峰注射剂有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-112684093-B | Quality detection method of eleven-prescription medicinal liquor | 广西中医药大学 | 2022-11-25 | — | — | CN | claimed |
| CN-113252835-B | Thin-layer chromatography identification method of Yanhuweian capsules | 段复华 | 2022-08-16 | — | — | CN | claimed |
| CN-110051713-B | Antidiarrheal semen formula particle, preparation method and detection method | 青海普兰特药业有限公司 | 2021-10-01 | — | — | CN | claimed |
| CN-113252835-A | Thin-layer chromatography identification method of Yanhuweian capsules | 段复华 | 2021-08-13 | — | — | CN | claimed |
| CN-112684093-A | Quality detection method of eleven-prescription medicinal liquor | 广西中医药大学 | 2021-04-20 | — | — | CN | claimed |
| CN-111122735-A | Ligusticum wallichii medicine quality detection method | 贵州景峰注射剂有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-110051713-A | A kind of seed of Cortex Holarrhenae Antidysentericae granule, preparation method and detection method | 青海普兰特药业有限公司 | 2019-07-26 | — | — | CN | claimed |
| CN-106146597-A | A kind of saringosterol compound and extracting method, application | 浙江海洋大学 | 2016-11-23 | — | — | CN | claimed |
| US-20120141524-A1 | ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2012-06-07 | — | — | US | claimed |
| CN-101168009-B | Quality control method of macaque stone bovinebezoar powder | GUANGZHOU QIXING PHARMACY GROUP CO LTD | 2010-10-06 | — | — | CN | claimed |
| US-20100210869-A1 | ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2010-08-19 | — | — | US | claimed |
| CN-101584809-A | Medicine for treating cold-type yellow water disease and preparation and detection methods thereof | GANSU QIZHENG TIBETAN MEDICINE (CN) | 2009-11-25 | — | — | CN | claimed |
| CN-101168009-A | Quality control method of macaque stone bovinebezoar powder | GUANGZHOU QIXING PHARMACY GROU (CN) | 2008-04-30 | — | — | CN | claimed |
| CN-1325098-C | Traditional Chinese medicine composition for improving immunity and preparation method and quality control method thereof | WANG WEIMING (CN) | 2007-07-11 | — | — | CN | claimed |
| CN-1788775-A | Traditional Chinese medicine composition for improving immunity and preparation method and quality control method thereof | WANG WEIMING (CN) | 2006-06-21 | — | — | CN | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120141524-A1 | ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF | BAX, API5, BCL2 | PRKCA 81/4885GLS2 4020/4885FAAH 645/4885 |
| US-20100210869-A1 | ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF | BAX, API5, BCL2 | PRKCA 81/4885GLS2 4020/4885FAAH 645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.